Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/47480
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Economic evaluation alongside n-of-1 trials: getting closer to the margin |
Author: | Karnon, J. Qizilbash, N. |
Citation: | Health Economics, 2001; 10(1):79-82 |
Publisher: | John Wiley & Sons Ltd |
Issue Date: | 2001 |
ISSN: | 1057-9230 1099-1050 |
Statement of Responsibility: | Jonathan Karnon and Nawab Qizilbash |
Abstract: | The n-of-1 trial is a particularly flexible form of randomized controlled trial that involves a single patient receiving multiple episodes of alternative therapies. Although n-of-1 trials are only applicable in certain treatment areas, the collection of economic data within such trials may provide unique advantages. This paper illustrates the issues around the use of economic n-of-1 trials with a hypothetical example, and discusses their potential for the estimation of individualized cost-effectiveness. |
Keywords: | Humans Osteoarthritis Chronic Disease Acetaminophen Analgesics, Non-Narcotic Anti-Inflammatory Agents, Non-Steroidal Episode of Care Sample Size Quality-Adjusted Life Years Cost-Benefit Analysis Randomized Controlled Trials as Topic |
Description: | Published in Health Economics, 2001; 10 (1):79-82 at www.interscience.wiley.com |
DOI: | 10.1002/1099-1050(200101)10:1<79::AID-HEC567>3.0.CO;2-Z |
Published version: | http://www3.interscience.wiley.com/cgi-bin/fulltext/76508493/PDFSTART |
Appears in Collections: | Aurora harvest Public Health publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.